GENE ONLINE|News &
Opinion
Blog

Astellas Pharma
Weekly cover : Companies Developing 2019-nCoV Vaccine
2020-02-04
Weekly in Asia|Dec-3
2020-01-02
M&A
Astellas Procures Xyphos Biosciences as Second Acquisition in December
2019-12-31
Weekly in Asia|Dec
2019-12-11
Weekly in Asia|Nov-2
2019-11-27
Weekly in Asia|Nov
2019-11-07
Weekly in Asia | SEP-2
2019-09-24
Weekly in Asia 20190609-0615
2019-06-21
Gilteritinib becomes first FLT3 targeted therapy for relapsed AML
2018-12-04
1 2 3
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top